Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TELA Bio, Inc. - Common stock
(NQ:
TELA
)
1.090
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about TELA Bio, Inc. - Common stock
< Previous
1
2
3
4
Next >
TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement
October 05, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
August 31, 2026
Company to reduce annual operating expenses by $17.0 million or 18% as part of broader efficiency program
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Second Quarter 2026 Financial Results
August 10, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 05, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
August 04, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 29, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Second Quarter 2026 Financial Results
July 20, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
May 27, 2026
Issued on behalf of Conexeu Sciences Inc.
From
Biotech Insider
Via
GlobeNewswire
TELA Bio Reports First Quarter 2026 Financial Results
May 12, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 07, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
April 30, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce First Quarter 2026 Financial Results
April 21, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
March 24, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
March 10, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 20, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 23, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
November 13, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
November 13, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Third Quarter 2025 Financial Results
November 04, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Appoints William Plovanic to Board of Directors
November 03, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
October 09, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Second Quarter 2025 Financial Results
August 11, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 08, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 23, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Second Quarter 2025 Financial Results
July 21, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
June 03, 2025
Based on market research, inguinal hernia repair is the most common type of hernia repair
From
TELA Bio, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
